ELECSYS HSV-2 IGG IMMUNOASSAY— 510(k) K121895

Substantially Equivalent

Roche Diagnostics

FDA 510(k) clearance K121895 for ELECSYS HSV-2 IGG IMMUNOASSAY, Substantially Equivalent on 2012-08-24. Applicant: Roche Diagnostics.

Clearance details

Applicant: Roche Diagnostics
Product code: Code JJX
Advisory panel: Clinical Chemistry
Date received: 2012-06-29
Decision date: 2012-08-24
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code JJX

product code JJX

Other: 2
Total: 2

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.